Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-04-03 Domzalski David President and CEO Grant or award +249,588 578,985
2020-04-03 Bruno Anthony D Director Grant or award +75,690 120,123
2020-04-03 Bruno Anthony D Director Grant or award +14,933 135,056
2020-04-03 Basta Steven L Director Grant or award +14,499 536,537
2020-03-31 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,688 $2.68 $5K 56,503
2020-03-31 Wiley Matthew T. Chief Commercial Officer Shares withheld for taxes −525 $2.68 $1K 67,051
2020-03-31 Stuart Iain Chief Scientific Officer Shares withheld for taxes −1,940 $2.68 $5K 59,452
2020-03-31 Domzalski David President and CEO Shares withheld for taxes −4,456 $2.68 $12K 187,496
2020-03-23 Saik Andrew Chief Financial Officer Grant or award +50,000 50,000
2020-03-23 Saik Andrew Chief Financial Officer Grant or award · Stock Options +100,000 100,000
2020-03-19 Sandoval Elisabeth Director Grant or award · Stock Option +45,000 45,000
2020-03-19 Bruno Anthony D Director Grant or award · Stock Option +45,000 45,000
2020-03-19 Bright Rex Director Grant or award · Stock Option +45,000 45,000
2020-03-19 Basta Steven L Director Grant or award · Stock Option +45,000 45,000
2020-03-19 BARBARI SHARON SURREY Director Grant or award · Stock Option +45,000 45,000
2020-03-09 Wiley Matthew T. Chief Commercial Officer Grant or award +20,896 20,896
2020-03-09 Wiley Matthew T. Chief Commercial Officer Grant or award +46,680 67,576
2020-03-09 Wiley Matthew T. Chief Commercial Officer Grant or award · Stock Options +59,240 59,240
2020-03-09 Wiley Matthew T. Chief Commercial Officer Grant or award · Stock Options +57,086 57,086
2020-03-09 Stuart Iain Chief Scientific Officer Grant or award +7,306 7,306

Page 14 of 22 · 425 trades